Breast Cancer Research Program

Program Leaders: Angela DeMichele, MD, MSCE and Roger Greenberg, MD, PhD

Members of the Breast Cancer Research Program are focused on understanding the underlying causes of breast cancer to improve the detection, prevention, and treatment of this disease. They work together to achieve this goal by focusing on four key scientific areas:

  • Elucidation of the genetic and molecular mechanisms of breast cancer development and progression
  • Improvements in genetic risk assessment and development of novel prevention strategies
  • Development of innovative imaging approaches to improve breast cancer detection and the assessment of therapeutic response
  • Translation of laboratory discoveries to novel therapeutics and biomarkers of response and outcome

Members are highly interactive, as reflected in their leadership of multiple collaborative grants and numerous interdisciplinary translational clinical trials. In addition to facilitating intra- and inter-Programmatic collaborations, Program Leadership has emphasized breast cancer translational research as a major focus, implementing a breast cancer biospecimen bank and database, recruiting external faculty with important new expertise to the Program, and holding or participating in major Abramson Cancer Center (ACC) retreats that emphasize breast cancer research. The ACC's investment in clinical research, particularly the interdisciplinary Rena Rowan Breast Center, has facilitated patient-oriented research.

Breast Cancer Research Program Membership